FreeTrials & Tribulations Estimating overdiagnosis is hard—we need all the help we can get May 10, 2019Vol.45 No.19By Ruth Etzioni and Roman Gulati
FreeTrials & Tribulations A comparison of study designs for estimating overdiagnosis in cancer screening May 03, 2019Vol.45 No.18By Barry Kramer and Philip C. Prorok
FreeTrials & Tribulations SWOG’s 1501 study takes aim at the silo wall between cardiology and oncology March 22, 2019Vol.45 No.12By Justin Floyd
FreeTrials & Tribulations Glioblastoma patient is first to receive treatment under Right to Try. Our question is Why? February 01, 2019Vol.45 No.05By Kelly McBride Folkers and Alison Bateman-House
Trials & Tribulations Giving every patient an opportunity to participate in and benefit from cancer progress January 18, 2019Vol.45 No.03By Monica M. Bertagnolli
FreeTrials & Tribulations Deciphering genomic testing options for diverse patient populations in early-stage breast cancer November 16, 2018Vol.44 No.43By Adam Brufsky
Trials & Tribulations Biomarker linked to increased survival rates among certain brain tumor patients October 12, 2018Vol.44 No.38By Arnab Chakravarti
Trials & Tribulations How tumor-specific modulation frequencies were discovered October 05, 2018Vol.44 No.37By Boris C. Pasche
FreeTrials & Tribulations Shrinking oncology phase I clinical trials: If the drug is a breakthrough, why would you ever want to utilize the maximally tolerated dose? September 21, 2018Vol.44 No.35By Mark J. Ratain
FreeTrials & Tribulations Searching for Breast Cancer’s “Extreme Survivors” June 08, 2018Vol.44 No.23By Mark Burkard
